scanX
Gland Pharma
add_icon

Gland Pharma

2,932.40
+24.50
(0.84%)
Market Cap
48,372.78 Cr
PE Ratio
42.45
Volume
29,77,808.00
Day High - Low
2,969.00 - 2,851.10
52W High-Low
3,039.80 - 1,573.60
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
48,372.78 Cr
EPS
62.35
PE Ratio
42.45
PB Ratio
4.63
Book Value
627.88
EBITDA
1,945.90
Dividend Yield
0.69 %
Industry
Healthcare
Sector
Pharmaceuticals
Return on Equity
9.92
Debt to Equity
0.03
Analyst Rating and Forecast
- By Refinitiv from15 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+73.33 %
+73.33 %
Hold
Hold+6.67 %
+6.67 %
Sell
Sell+20.00 %
+20.00 %
Forecast For
Actual

Company News

View All News
Caret
neutral
Fosun Pharma likely to sell 5% stake in Gland Pharma20 hrs ago
Fosun Pharma is likely to offload a 5% equity stake in Gland Pharma via a block deal, according to reports by NDTV Profit.
positive
Gland Pharma VSEZ facility clears USFDA with zero observations3 days ago
Gland Pharma's VSEZ sterile oncology facility completed a USFDA inspection with zero Form 483 observations, signalling full regulatory compliance at the unit.
neutral
Gland Pharma schedules investor meetings in September4 days ago
Gland Pharma has announced a schedule of analyst and institutional investor meetings from September 3 to 24, 2026. The engagements include one-on-one sessions with Carnelian Capital and First Ray Capital, alongside group meetings arranged by ICICI Securities and JP Morgan.
View more

Peer Comparison Compare Peers on Screener

Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
Sun Pharmaceutical
1,899.00
#1 4,55,633.71
37.70
#1 61,673.90
12.69
#1 11,565
26.53
44.62
Divis Laboratories
9,100.00
2,41,576.41
83.91
11,067.00
13.95
2,568
65.50
65.13
Torrent Pharmaceuticals
4,857.00
1,84,744.67
86.89
13,886.20
20.34
2,138
3.28
44.72
Zydus Life Science
1,120.00
1,12,698.21
24.65
27,657.90
17.64
5,026
-34.90
45.48
Cipla
1,385.00
1,11,886.58
33.44
29,044.60
2.24
3,870
-39.18
36.26
Laurus Labs
1,840.00
99,333.61
92.77
6,867.80
22.01
890
#1 123.93
54.21
Lupin
2,110.00
96,476.07
#1 17.59
29,038.90
#1 26.75
5,356
16.00
25.94
Mankind Pharma
2,327.90
96,141.33
46.84
14,636.40
14.85
1,938
29.13
38.69
Dr Reddys Laboratories
1,151.00
96,070.41
30.28
35,058.60
3.90
4,158
-69.10
38.91
Aurobindo Pharma
1,653.10
95,115.72
25.23
34,145.20
5.56
3,503
25.21
54.82
Growth Rate
Revenue Growth
15.73 %
Net Income Growth
47.07 %
Cash Flow Change
12.75 %
ROE
30.01 %
ROCE
20.10 %
EBITDA Margin (Avg.)
13.41 %

Quarterly Financial Results

Quarterly Financials
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
681
916
852
895
935
1,216
1,132
1,109
1,168
931
1,110
1,000
824
1,246
1,427
1,583
1,580
1,453
1,466
1,443
1,469
1,563
1,571
1,759
1,854
1,862
Expenses
395
472
534
595
560
718
704
714
755
587
748
649
673
915
1,049
1,189
1,179
1,137
1,109
1,024
1,077
1,138
1,173
1,285
1,230
1,311
EBITDA
286
445
318
299
375
498
428
395
414
344
363
351
151
332
377
394
401
316
357
418
392
425
398
474
625
551
Operating Profit %
38 %
47 %
36 %
31 %
37 %
38 %
35 %
33 %
32 %
32 %
28 %
31 %
14 %
24 %
24 %
23 %
23 %
19 %
21 %
26 %
24 %
24 %
21 %
24 %
29 %
27 %
Depreciation
24
24
25
25
25
25
26
28
31
35
37
38
38
65
81
105
93
92
94
96
96
101
106
108
109
111
Interest
1
1
1
1
1
1
1
1
2
1
2
3
2
5
6
5
10
6
6
23
7
12
8
4
10
4
Profit Before Tax
262
420
293
273
349
472
401
366
381
309
324
311
111
261
290
283
298
218
257
299
288
313
284
362
506
435
Tax
67
106
74
69
89
121
99
93
95
79
83
79
33
67
96
91
106
75
93
95
102
97
100
101
139
118
Net Profit
195
314
219
204
260
351
302
273
286
229
241
232
79
194
194
192
192
144
164
205
187
216
184
262
367
317
EPS in ₹
12.57
20.24
14.12
12.83
15.93
21.41
18.37
16.62
17.40
13.93
14.65
14.08
4.78
11.79
11.78
11.65
11.68
8.73
9.93
12.42
11.32
13.08
11.15
15.87
22.26
19.23
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2020
2021
2022
2023
2024
2025
2026
Total Assets
4,086
6,496
7,834
8,778
10,661
11,225
12,511
Fixed Assets
968
954
1,502
1,571
3,947
4,147
4,492
Current Assets
2,846
5,124
5,852
6,901
5,645
6,783
7,527
Capital Work in Progress
189
338
191
177
238
151
342
Investments
0
0
155
0
0
0
0
Other Assets
2,930
5,204
5,986
7,030
6,477
6,927
7,676
Total Equity & Liabilities
4,086
6,496
7,834
8,778
10,661
11,225
12,511
Current Liabilities
359
513
582
729
1,398
1,565
1,608
Non Current Liabilities
81
80
94
90
539
509
545
Total Equity
3,646
5,903
7,158
7,959
8,724
9,151
10,358
Reserve & Surplus
3,631
5,887
7,141
7,942
8,707
9,134
10,342
Share Capital
16
16
16
17
17
17
17
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
2025
2026
Net Cash Flow
-67
323
-174
1,590
-1,552
2,199
803
Investing Activities
-761
-1,520
-999
1,211
-1,749
1,718
189
Operating Activities
701
605
791
364
997
915
1,031
Financing Activities
-7
1,239
35
15
-799
-434
-417
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Jun 2026
Promoter
58.25 %
58.14 %
58.02 %
58.00 %
58.00 %
57.87 %
57.86 %
57.86 %
57.86 %
57.86 %
57.86 %
57.86 %
57.86 %
51.83 %
51.83 %
51.83 %
51.83 %
51.83 %
51.83 %
51.83 %
51.83 %
51.77 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.01 %
0.01 %
0.00 %
4.91 %
0.00 %
3.59 %
6.88 %
4.47 %
5.04 %
6.90 %
7.39 %
7.91 %
7.58 %
7.30 %
8.74 %
DIIs
10.69 %
11.57 %
11.39 %
11.21 %
11.94 %
16.71 %
20.58 %
23.13 %
23.23 %
23.38 %
22.45 %
23.14 %
25.23 %
32.83 %
35.37 %
34.80 %
33.27 %
32.85 %
32.64 %
32.98 %
33.35 %
30.44 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
3.30 %
3.72 %
3.77 %
3.58 %
3.69 %
3.70 %
3.77 %
4.02 %
4.26 %
5.60 %
4.52 %
3.79 %
3.28 %
3.33 %
3.28 %
3.30 %
2.99 %
2.91 %
2.57 %
2.57 %
2.53 %
3.50 %
Others
27.76 %
26.58 %
26.81 %
27.21 %
26.37 %
21.71 %
17.78 %
14.98 %
14.64 %
13.16 %
10.27 %
15.22 %
10.04 %
5.12 %
5.04 %
5.04 %
5.01 %
5.02 %
5.06 %
5.04 %
4.98 %
5.55 %
No of Share Holders
84,467
98,203
1,09,326
1,09,097
1,09,098
1,17,339
1,27,879
1,48,469
1,50,578
1,81,747
1,61,627
1,36,021
1,22,375
1,22,665
1,22,358
1,21,075
1,13,788
1,10,671
97,151
94,578
91,500
1,08,266

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 20 18 20
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.26 1.06 0.69

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
16 Aug 2024 DIVIDEND Dividend
₹ 20.00 /share
 16 Aug 2024 1,800.25 1,958.25
30 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
 30 Aug 2024 1,800.25 1,849.00
04 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 04 Nov 2024 1,675.30 1,644.85
03 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 03 Feb 2025 1,672.75 1,530.45
20 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 20 May 2025 1,418.75 1,484.15
05 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 05 Aug 2025 2,000.80 1,982.80
14 Aug 2025 DIVIDEND Dividend
₹ 18.00 /share
 14 Aug 2025 1,484.15 1,950.30
28 Aug 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
 28 Aug 2025 1,484.15 1,928.25
03 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 03 Nov 2025 1,917.60 1,928.90
28 Jan 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 28 Jan 2026 1,698.95 1,675.90
15 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 15 May 2026 1,794.40 1,898.20
10 Aug 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 10 Aug 2026 2,377.70 2,600.45
11 Aug 2026 DIVIDEND Dividend
₹ 20.00 /share
 11 Aug 2026 1,898.20 2,667.30
25 Aug 2026 ANNUAL GENERAL MEETING Annual General Meeting
NA
 25 Aug 2026 1,898.20 2,801.60

Announcements

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation14 hrs ago
Conclusion Of USFDA Inspection At Companys Facilities Situated At Visakhapatnam3 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation4 days ago
Shareholder Meeting / Postal Ballot-Scrutinizers Report9 days ago
Shareholder Meeting / Postal Ballot-Outcome of AGM10 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 23, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 17, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementAug 14, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 11, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 10, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 10, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationAug 10, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 10, 2026
Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended June 30 2026Aug 10, 2026
Unaudited Financial Results For The Quarter Ended June 30 2026Aug 10, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 09, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 05, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 01, 2026
Letter To ShareholdersJul 31, 2026
Business Responsibility and Sustainability Reporting (BRSR)Jul 31, 2026
Reg. 34 (1) Annual Report.Jul 31, 2026
Notice Of 48Th AGMJul 31, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJul 30, 2026
Announcement under Regulation 30 (LODR)-Issue of SecuritiesJul 30, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 29, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 28, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 24, 2026
Board Meeting Intimation for Declaration Of Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30 2026Jul 24, 2026
Announcement under Regulation 30 (LODR)-Change in DirectorateJul 20, 2026
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportJul 20, 2026
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotJul 20, 2026
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jul 16, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jul 14, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 13, 2026
Closure of Trading WindowJun 26, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 22, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 19, 2026
Shareholder Meeting / Postal Ballot-Notice of Postal BallotJun 18, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 17, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 16, 2026
Announcement under Regulation 30 (LODR)-Resignation of DirectorJun 16, 2026
Announcement under Regulation 30 (LODR)-Resignation of DirectorJun 15, 2026
Announcement under Regulation 30 (LODR)-Change in DirectorateJun 15, 2026
Board Meeting Outcome for Outcome Of Board Meeting - 15.06.2026Jun 15, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 10, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 04, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJun 02, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 29, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 26, 2026
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 20, 2026

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Baroda BNP Paribas Health and Wellness Fund Direct-Growth
0.00%
-25000
-1.20%
-1.13%
Samco Small Cap Fund Direct-Growth
0.00%
-21743
-3.19%
-1.14%
Motilal Oswal Services Fund Direct-Growth
0.00%
-14706
-2.97%
-3.07%
JioBlackRock Nifty Smallcap 250 Index Fund Direct-Growth
0.00%
-14488
-0.93%
-0.94%
Navi Nifty Smallcap250 Momentum Quality 100 Index Fund Direct-Growth
0.00%
-4197
-2.60%
-2.50%
WhiteOak Capital Aggressive Hybrid Fund Direct-Growth
0.00%
-3976
-0.23%
0.00%
JioBlackRock Sector Rotation Fund Direct-Growth
0.00%
-997
-0.15%
-0.16%
Groww Nifty Smallcap 250 Momentum Quality 100 Index Fund Direct-Growth
0.00%
-792
-2.70%
-2.49%
DSP Nifty Smallcap 250 Index Fund Direct-Growth
0.00%
-567
-0.92%
-0.93%
Motilal Oswal BSE 1000 Index Fund Direct-Growth
0.00%
-234
-0.09%
-0.10%
Zerodha Nifty MidSmallcap400 50:50 Index Fund Direct-Growth
0.00%
-228
-0.46%
-0.45%
Navi Nifty MidSmallcap 400 Index Fund Direct-Growth
0.00%
-149
-0.31%
-0.32%
DSP Nifty 500 Index Fund Direct-Growth
0.00%
-61
-0.10%
-0.10%
Kotak Healthcare Fund Direct-Growth
0.00%
0
0.00%
-2.75%
LIC MF Balanced Advantage Fund Direct-Growth
0.00%
0
0.00%
0.00%
Axis ESG Integration Strategy Fund Direct-Growth
0.00%
0
0.00%
0.00%
Axis India Manufacturing Fund Direct-Growth
0.00%
0
0.00%
-0.49%
LIC MF Focused Fund Direct-Growth
0.00%
0
0.00%
0.00%
Axis Multicap Fund Direct-Growth
0.00%
0
0.00%
-0.49%
Axis Nifty 500 Index Fund Direct-Growth
0.00%
0
0.00%
-0.10%
Axis Nifty Smallcap 50 Index Fund Direct-Growth
0.00%
0
0.00%
-2.49%
Axis Small Cap Fund Direct-Growth
0.00%
0
0.00%
-0.79%
Axis Value Fund Direct-Growth
0.00%
0
0.00%
-0.49%
Bandhan BSE Healthcare Index Fund Direct-Growth
0.00%
0
0.00%
-1.23%
Bandhan Nifty Smallcap 250 Index Fund Direct-Growth
0.00%
0
0.00%
-0.93%

Technical Indicators

RSI(14)
Neutral
61.94
ATR(14)
Volatile
86.18
STOCH(9,6)
Neutral
61.17
STOCH RSI(14)
Oversold
15.31
MACD(12,26)
Bearish
-12.56
ADX(14)
Strong Trend
40.54
UO(9)
Bearish
51.73
ROC(12)
Downtrend And Accelerating
-1.44
WillR(14)
Neutral
-65.00
Bearish
4
Neutral
3
Bullish
2

About Gland Pharma

Gland Pharma Limited is an Indian generic injectables manufacturer specializing in sterile injectables, oncology, and ophthalmic products. Founded in 1978, the company operates primarily on a B2B model, selling products in over 60 countries. It has 8 manufacturing facilities in India, including 4 for finished formulations and 3 for APIs....more
Listing Date
20 Nov, 2020(5 Years, 9 Months, 16 Days)
Website
https://www.glandpharma.com
Chairperson NameSRINIVAS SADU
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Fundamental Screeners
Technical Screeners
Intraday Screeners
Price & Volume Screeners
Candlestick Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
Sensex Companies
Nifty 50 Companies
Nifty Next 50 Companies
Nifty Bank Companies
Finnifty Companies
Defence Stocks
Semi Conductor Stocks
Renewable Energy Stocks
AI Stocks
Cement Stocks
Penny Stocks
Multibagger Stocks
Breakout Stocks
Dividend Stocks
Large Cap Stocks
Mid Cap Stocks
Small Cap Stocks
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.
We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.
This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.
The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.
We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.
This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.
By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.
We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.

© 2025 - 2026 Raise Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016 | SEBI Research Analyst Registration No: INH000023357 Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320

Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai - 400104